Clinical Trials as Revenue Drivers: Interview with Matthew Amsden, CEO of ProofPilot

In this episode of Medsider Radio, our guest is Matthew Amsden,
the Founder and CEO of ProofPilot, a platform designed to help
people design, launch and participate in clinical trials.


ProofPilot’s mission statement revolves around making it
incredibly easy to run scientifically-valid research studies.
They’re dedicated to making research study participation
accessible, interesting, and fun.      


In this discussion with Matthew, we chatted about the importance
and feasibility of virtual clinical trials, how they can
potentially become a revenue driver, the origin story of
ProofPilot, and why their hybrid model is so popular.


Interview Highlights with Matthew Amsden


Who is Matthew Amsden and where did the idea for ProofPilot
begin?    

The importance of letting early customers try product
iterations.

How clinical studies can become a revenue driver. 

Various types of clinical trials and how they’re conducted on
the ProofPilot platform.

Risky and costly approaches to traditional clinical
studies.     

The synergy between data, compliance, and incentives.

How a virtual, hybrid model can solve problems when it comes
to traditional clinical trials. 

Matthew’s favorite business book, the mentor he most admires,
and the advice he’d give to his 30-year-old-self.



See more...